ICD-11 · 6C44

Disorders due to use of sedatives, hypnotics or anxiolytics

Disorders arising from use of sedatives, hypnotics or anxiolytics (e.g. benzodiazepines, barbiturates), characterized by loss of control, craving, tolerance, and withdrawal symptoms.

Symptoms

ICD-11 diagnostic criteria

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Disorders due to use of sedatives, hypnotics or anxiolytics are:

Synonyms and related terms

Loss of control over medication use, lack of control over medications, Strong craving for medications, medication craving, Medication tolerance, increased medication tolerance, Medication withdrawal symptoms, medication abstinence symptoms, continued medication use despite harm, use of medications despite health problems

Frequently asked questions

What are the symptoms of Disorders due to use of sedatives, hypnotics or anxiolytics?

Symptoms associated with Disorders due to use of sedatives, hypnotics or anxiolytics (ICD-11 6C44) include: Loss of control over amount and frequency of use, Strong craving for the substance, Tolerance (diminishing effect at same dose), Withdrawal symptoms, Use of medications despite health damage.

How is Disorders due to use of sedatives, hypnotics or anxiolytics diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Disorders due to use of sedatives, hypnotics or anxiolytics (6C44) include: zaburzenie związane z używaniem leków uspokajających, nasennych lub przeciwlękowych; szkody zdrowotne lub behawioralne wynikające z używania tych substancji.

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C44 – WHO ICD-11

Open in interactive browser →
Source: WHO ICD-11 (chapter 6 – Mental, behavioral and neurodevelopmental disorders). Used under CC BY-ND 3.0 IGO. ICD Diagnostica is not affiliated with or endorsed by WHO. Informational use only – does not replace clinical judgment.